CompletedNot Applicable

OSSEODENSIFICATION BY DENSAH BURS WITH ACTIVATED PLASMA ALBUMIN GEL FOR SINUS LIFTING WITH SIMULTANEOUS IMPLANT PLACEMENT

Egypt6 participantsStarted 2023-07-10

Plain-language summary

Aim of the current study is to evaluate clinically and radiographically transcrestal sinus lifting with densah burs with the use of activated plasma albumin gel associated with simultaneous implant placement.

Who can participate

Age range20 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient with missing maxillary premolars and molars. * Vertical bone height of 3-5 mm. * Good oral hygiene. * Non smokers. Exclusion Criteria: * Bad oral hygiene. * Presence of infection or periapical lesions in adjacent teeth. * Acute maxillary sinusitis. * Bruxism or clenching. * Medically compromised patients with a condition that affects the procedure (patients with bone diseases such as osteogenesis imperfecta and polyarthritis and patients on radiotherapy and chemotherapy)

What they're measuring

Postoperative pain

Timeframe: up to one week

Implant stability

Timeframe: up to 6 months

Vertical bone height gain

Timeframe: up to 6 months

Bone density around implant

Timeframe: up to 6 months

Trial details

NCT IDNCT06360263

SponsorEsraa Salem Kamal

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-07-10

View on ClinicalTrials.gov More Bone Loss, Alveolar trials